To view this email as a web page, click here.
October 17, 2018
 
Dermatology Times
Weight reduction, gluten-free diet recommended in PsO
A recent review by the National Psoriasis Foundation's medical board suggests that adults with psoriasis and/or psoriatic arthritis (PsA) may use dietary interventions to supplement standard medical therapies to reduce disease severity.
 
Dermatology Times
Selective oral tyrosine kinase inhibitor passes phase two in psoriasis
A novel tyrosine kinase 2 (TYK2) inhibitor may provide efficacy comparable to that of currently available biologic agents for psoriasis, without the adverse effects associated with JAK inhibitors, a study shows.
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.